MedTrace Logo

Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery

NCT02080689 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 286

Last updated 2017-02-27

No results posted yet for this study

Summary

The influence of Decipher test on urologist and patient treatment plan choices immediately post RP and at the time of PSA rise or BCR

Conditions

Interventions

OTHER

Decipher

Sponsors & Collaborators

  • Society of Urologic Oncology (SUO)

    collaborator UNKNOWN

  • GenomeDx Biosciences Corp

    lead INDUSTRY

Principal Investigators

  • Daniel W Lin, MD · The Society of Urologic Oncology (SUO)

  • John L Gore, MD · University of Washington

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2017-02-01
Completion
2017-02-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02080689 on ClinicalTrials.gov